17 results
DRS
EVAX
Evaxion Biotech A/S
25 Jun 21
Draft registration statement
12:00am
and Regenerative Medicine Advanced Therapy Designation
The FDA may grant accelerated approval to a product for a serious or life-threatening … for regenerative medicine therapies that meet certain conditions. Regenerative medicine therapies include cell therapies (both allogenic and autologous
F-1
EVAX
Evaxion Biotech A/S
8 Jan 21
Registration statement (foreign)
4:54pm
the development or approval process, but do not change the standards for approval.
Accelerated Approval Pathway and Regenerative Medicine Advanced … accelerated regulations are subject to prior review by the FDA.
Accelerated approval pathways are available for regenerative medicine therapies
F-1/A
EVAX
Evaxion Biotech A/S
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
the development or approval process, but do not change the standards for approval.
Accelerated Approval Pathway and Regenerative Medicine Advanced Therapy … accelerated regulations are subject to prior review by the FDA.
Accelerated approval pathways are available for regenerative medicine therapies that meet
20-F
bdqrsk5hil egj
7 Apr 21
Annual report (foreign)
4:31pm
424B4
yzls9p 6e
5 Nov 21
Prospectus supplement with pricing info
4:47pm
DRS/A
8n9d5
25 Nov 20
Draft registration statement (amended)
12:00am
424B4
pc421jpohmj0g
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
kdy3g2lcav5z tc589
3 Nov 21
Registration statement (foreign) (amended)
7:50am
F-1/A
f6penz1tbfjtgav dyo
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
F-1
nym4yvcovatvpv959
26 Oct 21
Registration statement (foreign)
7:02am
DRS/A
37hpl
16 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
6ufv77r d2eyzv748
4 Jan 21
Draft registration statement (amended)
12:00am
DRS
i433jycblkch
22 Oct 20
Draft registration statement
12:00am
F-1/A
3xi5vhydkvudv85ms
25 Jan 21
Registration statement (foreign) (amended)
7:01am
- Prev
- 1
- Next